FdaApplication

ANDA 206858

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDING INC
application_typeANDA
approval_date2020-07-06

Products (1)

ProductActive ingredientStrengthDosage form
DALFAMPRIDINEDALFAMPRIDINE10MGTABLET, EXTENDED RELEASE;ORAL

1 product